ZFAS1 and gastric cancer: The knockdown of ZFAS1 via siRNA in gastric-cancer cell lines results in decreased cell migration, invasion, and proliferation, providing evidence that ZFAS1 may serve as an independent prognostic biomarker as well as a therapeutic target in gastric cancer [113].